NYSE:ALB

Albemarle Stock Forecast, Price & News

$135.25

-0.63 (-0.46 %)

(As of 12/2/2020 12:00 AM ET)

Add

Compare

Today's Range

$132.16

Now: $135.25▼

$136.00

50-Day Range

$90.78

MA: $111.45▼

$137.66

52-Week Range

$48.89

Now: $135.25▼

$138.19

Volume1.52 million shs

Average Volume1.32 million shs

Market Capitalization$14.40 billion

P/E Ratio37.78

Dividend Yield1.13%

Beta1.57

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. The company operates in three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. The Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment offers hydroprocessing catalysts together with isomerization and akylation catalysts; fluidized catalytic cracking catalysts and additives; and performance catalyst solutions comprising organometallics and curatives. The company serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1994 and is headquartered in Charlotte, North Carolina.

Beat the Market (BTM) Rank^™

2.1 Analyst's Opinion

Consensus Rating
Albemarle has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 8 buy ratings, 10 hold ratings, and 5 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $95.92, Albemarle has a forecasted downside of 29.1% from its current price of $135.25.
Amount of Analyst Coverage
Albemarle has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.7 Community Rank

Outperform Votes
Albemarle has received 690 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Albemarle has received 589 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Albemarle has received 53.95% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Albemarle and other stocks. Vote “Outperform” if you believe ALB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ALB will underperform the S&P 500 over the long term. You may vote once every thirty days.

3.3 Dividend Strength

Dividend Yield
Albemarle has a dividend yield of 1.13%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Albemarle has been increasing its dividend for 26 years.
Dividend Coverage
The dividend payout ratio of Albemarle is 25.50%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Albemarle will have a dividend payout ratio of 38.69% next year. This indicates that Albemarle will be able to sustain or increase its dividend.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Albemarle insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $28,424,911.00 in company stock.
Percentage Held by Insiders
Only 1.07% of the stock of Albemarle is held by insiders.
Percentage Held by Institutions
86.49% of the stock of Albemarle is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Albemarle are expected to grow by 1.27% in the coming year, from $3.93 to $3.98 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Albemarle is 37.78, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 20.94.
Price to Earnings Ratio vs. Sector
The P/E ratio of Albemarle is 37.78, which means that it is trading at a more expensive P/E ratio than the Basic Materials sector average P/E ratio of about 23.05.
Price to Earnings Growth Ratio
Albemarle has a PEG Ratio of 3.26. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Albemarle has a P/B Ratio of 3.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.08 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Plastics materials & resins

Sub-IndustrySpecialty Chemicals

SectorBasic Materials

Current SymbolNYSE:ALB

Previous Symbol

CUSIP01265310

CIK915913

Webwww.albemarle.com

Phone980-299-5700

Employees6,000

Debt

Debt-to-Equity Ratio0.68

Current Ratio1.38

Quick Ratio0.87

Price-To-Earnings

Trailing P/E Ratio37.78

Forward P/E Ratio34.41

P/E Growth3.26

Sales & Book Value

Annual Sales$3.59 billion

Price / Sales4.01

Cash Flow$8.03 per share

Price / Cash Flow16.84

Book Value$40.63 per share

Price / Book3.33

Profitability

EPS (Most Recent Fiscal Year)$6.04

Net Income$533.23 million

Net Margins11.77%

Return on Equity11.96%

Return on Assets4.97%

Miscellaneous

Outstanding Shares106,460,000

Market Cap$14.40 billion

Next Earnings Date2/17/2021 (Estimated)

OptionableOptionable

$135.25

-0.63 (-0.46 %)

(As of 12/2/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive ALB News and Ratings via Email

Sign-up to receive the latest news and ratings for ALB and its competitors with MarketBeat's FREE daily newsletter.

Albemarle (NYSE:ALB) Frequently Asked Questions

How has Albemarle's stock been impacted by Coronavirus?

Albemarle's stock was trading at $70.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALB stock has increased by 93.0% and is now trading at $135.25.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Albemarle?

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 5 sell ratings, 10 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Albemarle or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Albemarle?

Wall Street analysts have given Albemarle a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Albemarle wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Albemarle's next earnings date?

Albemarle is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Albemarle.

How were Albemarle's earnings last quarter?

Albemarle Co. (NYSE:ALB) posted its quarterly earnings results on Monday, November, 9th. The specialty chemicals company reported $1.09 EPS for the quarter, beating the Zacks' consensus estimate of $0.78 by $0.31. The specialty chemicals company had revenue of $746.87 million for the quarter, compared to analysts' expectations of $734.75 million. Albemarle had a net margin of 11.77% and a return on equity of 11.96%. The business's quarterly revenue was down 15.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.53 EPS.
View Albemarle's earnings history.

How often does Albemarle pay dividends? What is the dividend yield for Albemarle?

Albemarle announced a quarterly dividend on Tuesday, October 27th. Shareholders of record on Friday, December 11th will be paid a dividend of $0.385 per share on Monday, January 4th. This represents a $1.54 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date is Thursday, December 10th.
View Albemarle's dividend history.

What guidance has Albemarle issued on next quarter's earnings?

Albemarle issued an update on its FY20 earnings guidance on Wednesday, November, 4th. The company provided EPS guidance of $3.80-4.15 for the period, compared to the Thomson Reuters consensus estimate of $3.48. The company issued revenue guidance of $3.05-3.15 billion, compared to the consensus revenue estimate of $3.04 billion.

What price target have analysts set for ALB?

23 analysts have issued twelve-month target prices for Albemarle's stock. Their forecasts range from $50.00 to $140.00. On average, they expect Albemarle's share price to reach $95.92 in the next year. This suggests that the stock has a possible downside of 29.1%.
View analysts' price targets for Albemarle.

Who are some of Albemarle's key competitors?

Some companies that are related to Albemarle include The Sherwin-Williams (SHW), Ecolab (ECL), Valaris (VAL), Celanese (CE), International Flavors & Fragrances (IFF), RPM International (RPM), Ashland Global (ASH), Quaker Chemical (KWR), NewMarket (NEU), W. R. Grace & Co. (GRA), PolyOne (POL), Balchem (BCPC), Sensient Technologies (SXT), H.B. Fuller (FUL) and Stepan (SCL).
View all competitors.

What other stocks do shareholders of Albemarle own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial Co. (IFC.TO) (IFC), Constellation Software Inc. (CSU.TO) (CSU), AutoCanada Inc. (ACQ.TO) (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy Inc. (VET.TO) (VET), Wheaton Precious Metals Corp. (WPM.TO) (WPM), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Who are Albemarle's key executives?

Albemarle's management team includes the following people:

Mr. Jerry Kent Masters Jr., Pres, CEO & Chairman (Age 59, Pay $150k)
Mr. Scott A. Tozier, Exec. VP & CFO (Age 54, Pay $974.29k)
Ms. Karen G. Narwold Esq., Exec. VP, Chief Admin. Officer, Gen. Counsel & Corp. Sec. (Age 60, Pay $861.02k)
Mr. Luther C. Kissam IV, Director (Age 55, Pay $2M)
Mr. Raphael Goszcz Crawford, Pres of Catalysts Global Bus. Unit (Age 44, Pay $1.01M)
Mr. Netha N. Johnson Jr., Pres of Bromine Specialties Global Bus. Unit (Age 49, Pay $1.51M)
Mr. John Clarence Barichivich III, VP, Corp. Controller & Chief Accounting Officer (Age 52)
Mr. Patrick Thompson, Chief Information Officer
Ms. Sharon B. McGee, VP of Corp. Devel. & Investor Relations
Ms. DeeAnne J. Marlow, Sr. VP & Chief HR Officer (Age 54)

What is Albemarle's stock symbol?

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Who are Albemarle's major shareholders?

Albemarle's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.06%), State Street Corp (6.09%), KAMES CAPITAL plc (1.06%), ProShare Advisors LLC (1.02%), US Bancorp DE (0.77%) and Charles Schwab Investment Management Inc. (0.66%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends for Albemarle.

Which major investors are selling Albemarle stock?

ALB stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, ProShare Advisors LLC, BlackRock Inc., AXA S.A., Morgan Stanley, US Bancorp DE, Victory Capital Management Inc., and Public Employees Retirement System of Ohio. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam, Raphael Goszcz Crawford, and Scott Tozier.
View insider buying and selling activity for Albemarle.

Which major investors are buying Albemarle stock?

ALB stock was purchased by a variety of institutional investors in the last quarter, including Payden & Rygel, First Trust Advisors LP, Standard Life Aberdeen plc, Cibc World Markets Corp, Axel Capital Management LLC, Main Street Research LLC, AQR Capital Management LLC, and KAMES CAPITAL plc. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow, and Eric Norris.
View insider buying and selling activity for Albemarle.

How do I buy shares of Albemarle?

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Albemarle's stock price today?

One share of ALB stock can currently be purchased for approximately $135.25.

How big of a company is Albemarle?

Albemarle has a market capitalization of $14.40 billion and generates $3.59 billion in revenue each year. The specialty chemicals company earns $533.23 million in net income (profit) each year or $6.04 on an earnings per share basis. Albemarle employs 6,000 workers across the globe.

What is Albemarle's official website?

The official website for Albemarle is www.albemarle.com.

How can I contact Albemarle?

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]

This page was last updated on 12/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings